Hereditary Cancer Testing

According to the National Cancer Institute, inherited genetic mutations are thought to play a role in 5 to 10% of all cancers.

GoPath has developed GoPathGenetics - a series that examines genes associated with hereditary breast, ovarian, prostate, colon and other hereditary cancers. 

These panels include:

          •     BRCAnow® for Hereditary Breast and Ovarian Cancer 
          •     LynchNowTM for Cancers Associated with Lynch syndrome